Page last updated: 2024-08-23

s-adenosylmethionine and Basedow Disease

s-adenosylmethionine has been researched along with Basedow Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Majdoub, M; Lantz, M; Spégel, P1
Al Majdoub, M; Lantz, M; Spégel, P1

Trials

1 trial(s) available for s-adenosylmethionine and Basedow Disease

ArticleYear
Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels.
    Thyroid : official journal of the American Thyroid Association, 2017, Volume: 27, Issue:9

    Topics: Adult; Antithyroid Agents; Carnitine; Combined Modality Therapy; Fatty Acids; Fatty Acids, Volatile; Female; Follow-Up Studies; Graves Disease; Hormone Replacement Therapy; Humans; Male; Metabolomics; Methimazole; Middle Aged; Molecular Weight; Principal Component Analysis; Sweden; Thyroid Gland; Thyroxine

2017

Other Studies

1 other study(ies) available for s-adenosylmethionine and Basedow Disease

ArticleYear
Alterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves' disease.
    Endocrine, 2019, Volume: 63, Issue:1

    Topics: Adult; Antithyroid Agents; Carnitine; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Predictive Value of Tests; Weight Gain

2019